# Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer

> **NCT02556632** · PHASE2 · COMPLETED · sponsor: **Gary Morrow** · enrollment: 191 (actual)

## Conditions studied

- Breast Carcinoma
- Pain
- Radiation-Induced Dermatitis
- Stage 0 Breast Cancer

## Interventions

- **DRUG:** Curcumin-based Gel
- **PROCEDURE:** Dermatologic Complications Management
- **OTHER:** Laboratory Biomarker Analysis
- **OTHER:** Placebo
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT02556632
- **Lead sponsor:** Gary Morrow
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-13
- **Primary completion:** 2016-09-30
- **Final completion:** 2016-09-30
- **Target enrollment:** 191 (ACTUAL)
- **Last updated:** 2017-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02556632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02556632, "Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02556632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*